Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Paulson & Co. buys Exxon, exits Qiagen in Q4 » 17:05
02/16/21
02/16
17:05
02/16/21
17:05
THRY

Thryv Holdings

$27.25 /

+3.4 (+14.26%)

, ALXN

Alexion

$156.75 /

-1.7 (-1.07%)

, RP

RealPage

$86.89 /

+0.04 (+0.05%)

, AEL

American Equity

$30.00 /

+0.29 (+0.98%)

, XOM

Exxon Mobil

$52.04 /

+1.52 (+3.01%)

, QGEN

Qiagen

$55.20 /

-0.85 (-1.52%)

, LEA

Lear

$162.79 /

+3.07 (+1.92%)

, ENDP

Endo

$9.32 /

+0.29 (+3.21%)

, HZNP

Horizon Therapeutics

$86.96 /

-3.58 (-3.95%)

, GOLD

Barrick Gold

$21.70 /

-0.44 (-1.99%)

, SA

Seabridge Gold

$18.36 /

-0.18 (-0.97%)

, NMRK

Newmark

$8.67 /

-0.045 (-0.52%)

, AU

AngloGold Ashanti

$22.85 /

-1.165 (-4.85%)

, BHC

Bausch Health

$31.45 /

+0.2 (+0.64%)

, BSIG

BrightSphere

$20.44 /

+0.54 (+2.71%)

, GLD

SPDR Gold Shares

$168.27 /

-2.46 (-1.44%)

, NG

NovaGold

$9.03 /

-0.33 (-3.53%)

John Paulson's…

John Paulson's Paulson & Co. disclosed in an SEC filing the firm's holdings as of December 31, 2020. Paulson's nine new buys during the fourth quarter included, by size of position, Thryv Holdings (THRY), Alexion Pharmaceuticals (ALXN), RealPage (RP), American Equity Investment Life Holding (AEL), and Exxon Mobil (XOM). The fund exited five positions during the quarter, including by size of previous position Qiagen (QGEN) and Lear Corporation (LEA). Paulson increased its stake in six holdings, including by size of previous position Endo (ENDP), Horizon Therapeutics (HZNP), Barrick Gold (GOLD), Seabridge Gold (SA), and Newmark Group (NMRK). The fund decreased its stake in one holding, namely AngloGold (AU). Paulson's top holdings as of December 31, in order of size, were Horizon Therapeutics, Bausch Health (BHC), Brightsphere Investment Group (BSIG), SPDR Gold Shares (GLD), and Novagold Resources (NG).

ShowHide Related Items >><<
XOM Exxon Mobil
$52.04 /

+1.52 (+3.01%)

THRY Thryv Holdings
$27.25 /

+3.4 (+14.26%)

SA Seabridge Gold
$18.36 /

-0.18 (-0.97%)

RP RealPage
$86.89 /

+0.04 (+0.05%)

QGEN Qiagen
$55.20 /

-0.85 (-1.52%)

NMRK Newmark
$8.67 /

-0.045 (-0.52%)

NG NovaGold
$9.03 /

-0.33 (-3.53%)

LEA Lear
$162.79 /

+3.07 (+1.92%)

HZNP Horizon Therapeutics
$86.96 /

-3.58 (-3.95%)

GOLD Barrick Gold
$21.70 /

-0.44 (-1.99%)

GLD SPDR Gold Shares
$168.27 /

-2.46 (-1.44%)

ENDP Endo
$9.32 /

+0.29 (+3.21%)

BSIG BrightSphere
$20.44 /

+0.54 (+2.71%)

BHC Bausch Health
$31.45 /

+0.2 (+0.64%)

AU AngloGold Ashanti
$22.85 /

-1.165 (-4.85%)

ALXN Alexion
$156.75 /

-1.7 (-1.07%)

AEL American Equity
$30.00 /

+0.29 (+0.98%)

THRY Thryv Holdings
$27.25 /

+3.4 (+14.26%)

11/17/20 William Blair
Thryv Holdings initiated with an Outperform at William Blair
ALXN Alexion
$156.75 /

-1.7 (-1.07%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/04/21 Piper Sandler
Alexion downgraded to Neutral from Overweight at Piper Sandler
01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
RP RealPage
$86.89 /

+0.04 (+0.05%)

02/04/21 William Blair
RealPage downgraded to Market Perform from Outperform at William Blair
12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
12/22/20 Baird
RealPage downgraded to Neutral from Outperform at Baird
12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
AEL American Equity
$30.00 /

+0.29 (+0.98%)

01/15/21 Raymond James
American Equity upgraded to Outperform from Market Perform at Raymond James
01/15/21 Raymond James
American Equity upgraded to Outperform from Market Perform at Raymond James
01/07/21 B. Riley
American Equity upgraded to Buy from Neutral at B. Riley Securities
12/15/20 Credit Suisse
American Equity initiated with Outperform, $35 target at Credit Suisse
XOM Exxon Mobil
$52.04 /

+1.52 (+3.01%)

02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
QGEN Qiagen
$55.20 /

-0.85 (-1.52%)

02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
12/10/20 Exane BNP Paribas
Qiagen price target raised to EUR 54 from EUR 52 at Exane BNP Paribas
LEA Lear
$162.79 /

+3.07 (+1.92%)

02/08/21 Credit Suisse
Lear price target raised to $185 from $180 at Credit Suisse
01/22/21 JPMorgan
Lear upgraded to Overweight on vehicle electrification at JPMorgan
01/22/21 JPMorgan
Lear upgraded to Overweight from Neutral at JPMorgan
01/20/21 Deutsche Bank
Lear price target raised to $165 from $150 at Deutsche Bank
ENDP Endo
$9.32 /

+0.29 (+3.21%)

01/19/21 Citi
Endo price target raised to $9 from $7 at Citi
01/04/21 Piper Sandler
Endo price target raised to $12 from $6 at Piper Sandler
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
10/20/20 H.C. Wainwright
BioSpecifics downgraded to Neutral from Buy at H.C. Wainwright
HZNP Horizon Therapeutics
$86.96 /

-3.58 (-3.95%)

02/08/21 Wedbush
Viela Bio downgraded to Neutral at Wedbush on Horizon acquisition bid
02/02/21 Jefferies
Viela deal could be 'transformative' for Horizon growth, says Jefferies
02/02/21 H.C. Wainwright
Viela Bio downgraded to Neutral from Buy at H.C. Wainwright
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
GOLD Barrick Gold
$21.70 /

-0.44 (-1.99%)

02/10/21 JPMorgan
Barrick Gold initiated with a Neutral at JPMorgan
02/08/21 Stifel
Barrick Gold price target raised to C$43.25 from C$42.50 at Stifel
01/10/21 National Bank
Barrick Gold upgraded to Outperform from Sector Perform at National Bank
01/06/21 Barclays
Barrick Gold upgraded to Overweight from Equal Weight at Barclays
SA Seabridge Gold
$18.36 /

-0.18 (-0.97%)

12/14/20 B. Riley
Seabridge Gold price target raised to $109 from $96 at B. Riley Securities
09/03/20 B. Riley
Seabridge Gold assumed with a Buy at B. Riley FBR
06/16/20 B. Riley
Seabridge Gold price target lowered to $40 from $42 at B. Riley FBR
NMRK Newmark
$8.67 /

-0.045 (-0.52%)

01/25/21 Goldman Sachs
Newmark initiated with a Buy at Goldman Sachs
12/23/20 Piper Sandler
Newmark price target raised to $7.50 from $5 at Piper Sandler
04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
AU AngloGold Ashanti
$22.85 /

-1.165 (-4.85%)

02/11/21 Goldman Sachs
AngloGold Ashanti initiated with a Buy at Goldman Sachs
12/07/20 BMO Capital
AngloGold upgraded to Outperform from Market Perform at BMO Capital
09/14/20 RBC Capital
AngloGold coverage transferred with an Outperform at RBC Capital
07/31/20 BMO Capital
AngloGold downgraded to Market Perform from Outperform at BMO Capital
BHC Bausch Health
$31.45 /

+0.2 (+0.64%)

02/16/21 JPMorgan
Bausch Health price target raised to $38 from $32 at JPMorgan
01/22/21
Fly Intel: Top five analyst downgrades
01/22/21 Piper Sandler
Bausch Health downgraded to Neutral from Overweight at Piper Sandler
01/15/21 Jefferies
Bausch Health price target raised to $33 from $27 at Jefferies
BSIG BrightSphere
$20.44 /

+0.54 (+2.71%)

07/29/20 BofA
BrightSphere upgraded to Neutral from Underperform at BofA
07/28/20 Keefe Bruyette
BrightSphere upgraded to Outperform from Market Perform at Keefe Bruyette
05/12/20 Morgan Stanley
BrightSphere upgraded to Equal Weight from Underweight at Morgan Stanley
04/08/20 Morgan Stanley
BrightSphere downgraded to Underweight at Morgan Stanley
GLD SPDR Gold Shares
$168.27 /

-2.46 (-1.44%)

NG NovaGold
$9.03 /

-0.33 (-3.53%)

XOM Exxon Mobil
$52.04 /

+1.52 (+3.01%)

RP RealPage
$86.89 /

+0.04 (+0.05%)

QGEN Qiagen
$55.20 /

-0.85 (-1.52%)

NMRK Newmark
$8.67 /

-0.045 (-0.52%)

LEA Lear
$162.79 /

+3.07 (+1.92%)

HZNP Horizon Therapeutics
$86.96 /

-3.58 (-3.95%)

GOLD Barrick Gold
$21.70 /

-0.44 (-1.99%)

ENDP Endo
$9.32 /

+0.29 (+3.21%)

BSIG BrightSphere
$20.44 /

+0.54 (+2.71%)

BHC Bausch Health
$31.45 /

+0.2 (+0.64%)

ALXN Alexion
$156.75 /

-1.7 (-1.07%)

AEL American Equity
$30.00 /

+0.29 (+0.98%)

  • 07
    Aug
  • 20
    May
XOM Exxon Mobil
$52.04 /

+1.52 (+3.01%)

QGEN Qiagen
$55.20 /

-0.85 (-1.52%)

GOLD Barrick Gold
$21.70 /

-0.44 (-1.99%)

GLD SPDR Gold Shares
$168.27 /

-2.46 (-1.44%)

ENDP Endo
$9.32 /

+0.29 (+3.21%)

ALXN Alexion
$156.75 /

-1.7 (-1.07%)

AEL American Equity
$30.00 /

+0.29 (+0.98%)

XOM Exxon Mobil
$52.04 /

+1.52 (+3.01%)

RP RealPage
$86.89 /

+0.04 (+0.05%)

QGEN Qiagen
$55.20 /

-0.85 (-1.52%)

LEA Lear
$162.79 /

+3.07 (+1.92%)

HZNP Horizon Therapeutics
$86.96 /

-3.58 (-3.95%)

ENDP Endo
$9.32 /

+0.29 (+3.21%)

BHC Bausch Health
$31.45 /

+0.2 (+0.64%)

ALXN Alexion
$156.75 /

-1.7 (-1.07%)

AEL American Equity
$30.00 /

+0.29 (+0.98%)

ALXN Alexion
$156.75 /

-1.7 (-1.07%)

XOM Exxon Mobil
$52.04 /

+1.52 (+3.01%)

QGEN Qiagen
$55.20 /

-0.85 (-1.52%)

NG NovaGold
$9.03 /

-0.33 (-3.53%)

HZNP Horizon Therapeutics
$86.96 /

-3.58 (-3.95%)

GOLD Barrick Gold
$21.70 /

-0.44 (-1.99%)

ENDP Endo
$9.32 /

+0.29 (+3.21%)

BSIG BrightSphere
$20.44 /

+0.54 (+2.71%)

BHC Bausch Health
$31.45 /

+0.2 (+0.64%)

ALXN Alexion
$156.75 /

-1.7 (-1.07%)

GLD SPDR Gold Shares
$168.27 /

-2.46 (-1.44%)

Earnings
RealPage reports Q4 adjusted EPS 50c, consensus 48c » 17:07
02/10/21
02/10
17:07
02/10/21
17:07
RP

RealPage

$86.85 /

-0.04 (-0.05%)

Reports Q4 revenue…

Reports Q4 revenue $298.1M, consensus $294.66M. "In the fourth quarter, we continued to execute on our long-term strategy, and delivered another quarter of strong financial results. This performance continues to demonstrate the industry's need for digital solutions and the capabilities of the superior products RealPage has built over the last two decades," said Steve Winn, Chairman and CEO of RealPage.

ShowHide Related Items >><<
RP RealPage
$86.85 /

-0.04 (-0.05%)

RP RealPage
$86.85 /

-0.04 (-0.05%)

02/04/21 William Blair
RealPage downgraded to Market Perform from Outperform at William Blair
12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
12/22/20 Baird
RealPage downgraded to Neutral from Outperform at Baird
12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
RP RealPage
$86.85 /

-0.04 (-0.05%)

  • 20
    May
RP RealPage
$86.85 /

-0.04 (-0.05%)

Downgrade
RealPage downgraded to Market Perform from Outperform at William Blair » 04:48
02/04/21
02/04
04:48
02/04/21
04:48
RP

RealPage

$86.91 /

-0.06 (-0.07%)

William Blair analyst…

William Blair analyst Stephen Sheldon downgraded RealPage to Market Perform from Outperform without a price target. The analyst cites the expiration of the go-shop period ahead of the takeover by Thoma Bravo for $88.75 per share for the downgrade.

ShowHide Related Items >><<
RP RealPage
$86.91 /

-0.06 (-0.07%)

RP RealPage
$86.91 /

-0.06 (-0.07%)

12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
12/22/20 Baird
RealPage downgraded to Neutral from Outperform at Baird
12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
12/21/20 RBC Capital
RealPage downgraded to Sector Perform from Outperform at RBC Capital
RP RealPage
$86.91 /

-0.06 (-0.07%)

  • 20
    May
RP RealPage
$86.91 /

-0.06 (-0.07%)

Over a quarter ago
Hot Stocks
RealPage acquires WhiteSky » 09:10
01/04/21
01/04
09:10
01/04/21
09:10
RP

RealPage

$87.21 /

+0.09 (+0.10%)

RealPage announced the…

RealPage announced the acquisition of WhiteSky. WhiteSky provides managed communications services, enabling multifamily, student and other properties to provide managed bulk Internet, video, voice-over-internet protocol phone, and Wi-Fi services. The company scales through its nationwide network and teams of support and installation technicians. The company said the RealPage network, data center operations, and resident experience centers will complement the Whitesky offering, enabling quicker deployments, operational efficiencies, and an enhanced customer experience. At the end of 2020, WhiteSky served hundreds of properties totaling 48,000 units and 150,000 beds. Company annual revenue growth has been approximately 50% in recent years.

ShowHide Related Items >><<
RP RealPage
$87.21 /

+0.09 (+0.10%)

RP RealPage
$87.21 /

+0.09 (+0.10%)

12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
12/22/20 Baird
RealPage downgraded to Neutral from Outperform at Baird
12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
12/21/20 RBC Capital
RealPage downgraded to Sector Perform from Outperform at RBC Capital
RP RealPage
$87.21 /

+0.09 (+0.10%)

  • 20
    May
RP RealPage
$87.21 /

+0.09 (+0.10%)

Recommendations
RealPage price target raised to $101 from $80 at JMP Securities » 06:24
12/22/20
12/22
06:24
12/22/20
06:24
RP

RealPage

$87.27 /

+19.63 (+29.02%)

, CSGP

CoStar Group

$917.30 /

+13.71 (+1.52%)

JMP Securities analyst…

JMP Securities analyst Patrick Walravens raised the firm's price target on RealPage (RP) to $101 from $80 and keeps an Outperform rating on the shares after the company announced it would be acquired by Thoma Bravo for $8875 per share in cash. Walravens believes there might be another bidders for this "unique" asset, and thinks RealPage would make a "terrific" acquisition for CoStar (CSGP), and notes that other private equity firms have shown interest in RealPage in the past, including Vista Equity Partners in 2014.

ShowHide Related Items >><<
RP RealPage
$87.27 /

+19.63 (+29.02%)

CSGP CoStar Group
$917.30 /

+13.71 (+1.52%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

12/22/20 Baird
RealPage downgraded to Neutral from Outperform at Baird
12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
12/21/20 RBC Capital
RealPage downgraded to Sector Perform from Outperform at RBC Capital
12/21/20 KeyBanc
RealPage downgraded to Sector Weight from Overweight at KeyBanc
CSGP CoStar Group
$917.30 /

+13.71 (+1.52%)

11/23/20 Wells Fargo
CoStar Group price target raised to $990 from $915 at Wells Fargo
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
10/28/20 Needham
CoStar Group price target raised to $1,000 from $825 at Needham
10/28/20 Truist
CoStar Group price target raised to $1,000 from $850 at Truist
RP RealPage
$87.27 /

+19.63 (+29.02%)

CSGP CoStar Group
$917.30 /

+13.71 (+1.52%)

  • 21
    May
  • 20
    May
CSGP CoStar Group
$917.30 /

+13.71 (+1.52%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

CSGP CoStar Group
$917.30 /

+13.71 (+1.52%)

Downgrade
RealPage downgraded to Neutral from Outperform at Baird » 05:02
12/22/20
12/22
05:02
12/22/20
05:02
RP

RealPage

$87.27 /

+19.63 (+29.02%)

Baird analyst Joe Vruwink…

Baird analyst Joe Vruwink downgraded RealPage to Neutral from Outperform with an unchanged price target of $89 after the company entered into a definitive agreement to be acquired by Thoma Bravo for $88.75 per share.

ShowHide Related Items >><<
RP RealPage
$87.27 /

+19.63 (+29.02%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
12/21/20 RBC Capital
RealPage downgraded to Sector Perform from Outperform at RBC Capital
12/21/20 KeyBanc
RealPage downgraded to Sector Weight from Overweight at KeyBanc
12/21/20 Keefe Bruyette
RealPage downgraded to Market Perform from Outperform at Keefe Bruyette
RP RealPage
$87.27 /

+19.63 (+29.02%)

  • 20
    May
RP RealPage
$87.27 /

+19.63 (+29.02%)

Downgrade
RealPage downgraded to Market Perform from Outperform at BMO Capital » 17:30
12/21/20
12/21
17:30
12/21/20
17:30
RP

RealPage

$87.27 /

+19.63 (+29.02%)

BMO Capital analyst Keith…

BMO Capital analyst Keith Bachman downgraded RealPage to Market Perform from Outperform with a price target of $89, up from $75. The analyst citing the deal offer by Thoma Bravo, which announced it intends to acquire RealPage in a $10.2B all-cash transaction.

ShowHide Related Items >><<
RP RealPage
$87.27 /

+19.63 (+29.02%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

12/21/20 RBC Capital
RealPage downgraded to Sector Perform from Outperform at RBC Capital
12/21/20 KeyBanc
RealPage downgraded to Sector Weight from Overweight at KeyBanc
12/21/20 Keefe Bruyette
RealPage downgraded to Market Perform from Outperform at Keefe Bruyette
12/21/20 Wells Fargo
RealPage downgraded to Equal Weight from Overweight at Wells Fargo
RP RealPage
$87.27 /

+19.63 (+29.02%)

  • 20
    May
RP RealPage
$87.27 /

+19.63 (+29.02%)

Downgrade
RealPage downgraded to Sector Perform from Outperform at RBC Capital » 16:49
12/21/20
12/21
16:49
12/21/20
16:49
RP

RealPage

$87.27 /

+19.63 (+29.02%)

RBC Capital analyst…

RBC Capital analyst Matthew Hedberg downgraded RealPage to Sector Perform from Outperform with a price target of $88.75, up from $76, after the company entered into a definitive agreement to be acquired by Thoma Bravo for $88.75 per share.

ShowHide Related Items >><<
RP RealPage
$87.27 /

+19.63 (+29.02%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

12/21/20 KeyBanc
RealPage downgraded to Sector Weight from Overweight at KeyBanc
12/21/20 Keefe Bruyette
RealPage downgraded to Market Perform from Outperform at Keefe Bruyette
12/21/20 Wells Fargo
RealPage downgraded to Equal Weight from Overweight at Wells Fargo
11/03/20 DA Davidson
RealPage price target lowered to $65 from $70 at DA Davidson
RP RealPage
$87.27 /

+19.63 (+29.02%)

  • 20
    May
RP RealPage
$87.27 /

+19.63 (+29.02%)

Downgrade
RealPage downgraded to Sector Weight from Overweight at KeyBanc » 16:48
12/21/20
12/21
16:48
12/21/20
16:48
RP

RealPage

$87.27 /

+19.63 (+29.02%)

KeyBanc analyst Jason…

KeyBanc analyst Jason Celino downgraded RealPage to Sector Weight from Overweight without a price target after the company entered into a definitive agreement to be acquired by Thoma Bravo for $88.75 per share. The analyst calls the takeout an "early Christmas for shareholders."

ShowHide Related Items >><<
RP RealPage
$87.27 /

+19.63 (+29.02%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

12/21/20 Keefe Bruyette
RealPage downgraded to Market Perform from Outperform at Keefe Bruyette
12/21/20 Wells Fargo
RealPage downgraded to Equal Weight from Overweight at Wells Fargo
11/03/20 DA Davidson
RealPage price target lowered to $65 from $70 at DA Davidson
08/19/20
Fly Intel: Top five analyst initiations
RP RealPage
$87.27 /

+19.63 (+29.02%)

  • 20
    May
RP RealPage
$87.27 /

+19.63 (+29.02%)

On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:39
12/21/20
12/21
16:39
12/21/20
16:39
MRNA

Moderna

$138.24 /

-1.99 (-1.42%)

, PFE

Pfizer

$37.37 /

-0.315 (-0.84%)

, BNTX

BioNTech

$106.36 /

+2.27 (+2.18%)

, LMT

Lockheed Martin

$349.32 /

-6.91 (-1.94%)

, AJRD

Aerojet Rocketdyne

$52.78 /

+10.65 (+25.28%)

, RP

RealPage

$87.27 /

+19.63 (+29.02%)

, NKE

Nike

$143.97 /

+4.93 (+3.55%)

, WBAI

500.com

$3.79 /

+1.135 (+42.75%)

, NK

NantKwest

$16.02 /

+5.78 (+56.45%)

, QURE

uniQure

$38.51 /

-7.39 (-16.10%)

, FGEN

FibroGen

$40.01 /

-3.98 (-9.05%)

The major averages…

ShowHide Related Items >><<
WBAI 500.com
$3.79 /

+1.135 (+42.75%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

QURE uniQure
$38.51 /

-7.39 (-16.10%)

PFE Pfizer
$37.37 /

-0.315 (-0.84%)

NKE Nike
$143.97 /

+4.93 (+3.55%)

NK NantKwest
$16.02 /

+5.78 (+56.45%)

MRNA Moderna
$138.24 /

-1.99 (-1.42%)

LMT Lockheed Martin
$349.32 /

-6.91 (-1.94%)

FGEN FibroGen
$40.01 /

-3.98 (-9.05%)

AJRD Aerojet Rocketdyne
$52.78 /

+10.65 (+25.28%)

MRNA Moderna
$138.24 /

-1.99 (-1.42%)

12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/21/20 SVB Leerink
Moderna price target raised to $69 from $60 at SVB Leerink
12/21/20 Oppenheimer
Moderna price target raised to $178 from $157 at Oppenheimer
12/18/20 Barclays
Moderna price target raised to $169 from $84 at Barclays
PFE Pfizer
$37.37 /

-0.315 (-0.84%)

12/16/20
Fly Intel: Top five analyst downgrades
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
12/16/20 RBC Capital
Pfizer downgraded to Sector Perform from Outperform at RBC Capital
BNTX BioNTech
$106.36 /

+2.27 (+2.18%)

12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
12/14/20 Citi
Arcturus Therapeutics price target raised to $133 from $62 at Citi
12/08/20 Goldman Sachs
Goldman says FDA briefing documents supportive of approval for Pfizer vaccine
LMT Lockheed Martin
$349.32 /

-6.91 (-1.94%)

12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
12/22/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
12/21/20 Canaccord
Boeing not in position to challenge Aerojet bid, says Canaccord
12/21/20 RBC Capital
Aerojet Rocketdyne price target raised to $56 from $51 at RBC Capital
AJRD Aerojet Rocketdyne
$52.78 /

+10.65 (+25.28%)

12/21/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
RP RealPage
$87.27 /

+19.63 (+29.02%)

12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
12/22/20 Baird
RealPage downgraded to Neutral from Outperform at Baird
12/21/20 BMO Capital
RealPage downgraded to Market Perform from Outperform at BMO Capital
12/21/20 RBC Capital
RealPage downgraded to Sector Perform from Outperform at RBC Capital
NKE Nike
$143.97 /

+4.93 (+3.55%)

12/22/20 Argus
Nike price target raised to $165 from $140 at Argus
12/21/20 Jefferies
Nike price target raised to $140 from $117 at Jefferies
12/21/20 Baird
Nike near-term estimate upside limited, says Baird
12/21/20 Raymond James
Nike price target raised to $155 from $140 at Raymond James
WBAI 500.com
$3.79 /

+1.135 (+42.75%)

NK NantKwest
$16.02 /

+5.78 (+56.45%)

07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Piper Sandler
NantKwest initiated with an Overweight at Piper Sandler
QURE uniQure
$38.51 /

-7.39 (-16.10%)

12/22/20 Jefferies
uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies
12/22/20 RBC Capital
uniQure price target lowered to $53 from $61 at RBC Capital
12/22/20 H.C. Wainwright
uniQure price target lowered to $80 from $85 at H.C. Wainwright
12/21/20 Stifel
AMT-061 clinical hold 'obviously negative,' implications less clear, says Stifel
FGEN FibroGen
$40.01 /

-3.98 (-9.05%)

12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
RP RealPage
$87.27 /

+19.63 (+29.02%)

QURE uniQure
$38.51 /

-7.39 (-16.10%)

PFE Pfizer
$37.37 /

-0.315 (-0.84%)

NKE Nike
$143.97 /

+4.93 (+3.55%)

MRNA Moderna
$138.24 /

-1.99 (-1.42%)

LMT Lockheed Martin
$349.32 /

-6.91 (-1.94%)

FGEN FibroGen
$40.01 /

-3.98 (-9.05%)

BNTX BioNTech
$106.36 /

+2.27 (+2.18%)

AJRD Aerojet Rocketdyne
$52.78 /

+10.65 (+25.28%)

  • 23
    Jul
  • 25
    Jun
  • 20
    May
  • 19
    May
  • 12
    Feb
  • 06
    Feb
QURE uniQure
$38.51 /

-7.39 (-16.10%)

PFE Pfizer
$37.37 /

-0.315 (-0.84%)

NKE Nike
$143.97 /

+4.93 (+3.55%)

MRNA Moderna
$138.24 /

-1.99 (-1.42%)

LMT Lockheed Martin
$349.32 /

-6.91 (-1.94%)

RP RealPage
$87.27 /

+19.63 (+29.02%)

QURE uniQure
$38.51 /

-7.39 (-16.10%)

PFE Pfizer
$37.37 /

-0.315 (-0.84%)

NKE Nike
$143.97 /

+4.93 (+3.55%)

NK NantKwest
$16.02 /

+5.78 (+56.45%)

MRNA Moderna
$138.24 /

-1.99 (-1.42%)

LMT Lockheed Martin
$349.32 /

-6.91 (-1.94%)

FGEN FibroGen
$40.01 /

-3.98 (-9.05%)

BNTX BioNTech
$106.36 /

+2.27 (+2.18%)

AJRD Aerojet Rocketdyne
$52.78 /

+10.65 (+25.28%)

PFE Pfizer
$37.37 /

-0.315 (-0.84%)

NKE Nike
$143.97 /

+4.93 (+3.55%)

NK NantKwest
$16.02 /

+5.78 (+56.45%)

MRNA Moderna
$138.24 /

-1.99 (-1.42%)

FGEN FibroGen
$40.01 /

-3.98 (-9.05%)

BNTX BioNTech
$106.36 /

+2.27 (+2.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.